Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating Irrigation of Vancomycin and Tobramycin in Two-Stage Exchange Arthroplasty for PJI
NCT04662632Phase 2Completed
- Sponsor
- Osteal Therapeutics
- Start
- Nov 2021
- Primary completion
- Mar 2023
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vancomycin and tobramycin in prosthetic joint infection (PJI) (2 arms), sponsored by Osteal Therapeutics. Primary endpoint: Composite Endpoint of Overall Success at 90 days. Started Nov 2021; status: completed.
02
Drugs
vancomycintobramycin
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04662632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04662632.